Quick Answer
Nutex Health Inc. reported Total Revenue of $875.26 million for fiscal year 2025.
Nutex Health Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $875.26M +82.4% |
$479.95M +93.8% |
$247.65M +12.9% |
$219.29M -33.9% |
$331.53M +21.0% |
$274.03M +19954.5% |
| Net Income | $70.79M +35.9% |
$52.10M +213.8% |
-$45.79M +89.2% |
-$424.78M -420.4% |
$132.59M +25.1% |
$105.97M +1589.1% |
| Diluted EPS | $10.48 +8.2% |
$9.69 +193.3% |
-$10.39 +89.6% |
-$100.36 -45718.2% |
$0.22 +22.2% |
$0.18 |
| Total Assets | $918.52M +40.2% |
$655.32M +64.6% |
$398.25M -7.8% |
$431.75M +9.4% |
$394.65M +232242.5% |
$169.9K -97.5% |
| Cash and Equivalents | $185.57M +356.6% |
$40.64M +84.7% |
$22.00M -35.8% |
$34.26M -5.2% |
$36.12M +134014.2% |
$26.9K -97.5% |
| Long-Term Debt | $29.17M +29.9% |
$22.47M -14.6% |
$26.31M +14.2% |
$23.05M -70.8% |
$78.82M | — |
| Stockholders Equity | $329.45M +148.8% |
$132.44M +115.5% |
$61.45M -35.9% |
$95.86M -16.4% |
$114.65M +10212.2% |
-$1.13M -161.0% |
| R&D Expense | — | — | — | — | $285.9K -48.7% |
$557.3K -27.5% |
| Operating Income | $275.62M +110.9% |
$130.70M +511.3% |
-$31.77M +92.2% |
-$406.60M -338.8% |
$170.26M +11.2% |
$153.17M +2320.6% |
| Gross Profit | $444.28M +126.4% |
$196.26M +464.4% |
$34.77M +125.5% |
$15.42M -91.4% |
$179.28M +13.8% |
$157.61M +29305.5% |
| Shares Outstanding | 7.09M +28.6% |
5.51M +22.2% |
4.51M +4.1% |
4.33M +9.7% |
3.95M -25.2% |
5.28M +13.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $267.80M | +239.9% | +9.8% |
| Net Income | September 30, 2025 | $55.44M | +730.8% | +413.2% |
| Diluted EPS | September 30, 2025 | $7.76 | +551.2% | +363.1% |
| Total Assets | September 30, 2025 | $964.52M | +120.0% | +14.7% |
| Cash and Equivalents | September 30, 2025 | $166.05M | +254.0% | +71.7% |
| Long-Term Debt | September 30, 2025 | $25.57M | -4.6% | +25.0% |
| Stockholders Equity | September 30, 2025 | $317.17M | +424.8% | +34.8% |
| R&D Expense | March 31, 2022 | $73.8K | -3.9% | +2.1% |
| Operating Income | September 30, 2025 | $130.37M | +1249.1% | +287.1% |
| Gross Profit | September 30, 2025 | $154.88M | +606.7% | +24.0% |
| Shares Outstanding | September 30, 2025 | 6.91M | +32.4% | +4.7% |
- Nutex Health Inc. reported Total Revenue of $875.26 million for fiscal year 2025.
- Nutex Health Inc. showed an increase of +82.4% in Total Revenue compared to the prior fiscal year.
- Nutex Health Inc. reported Net Income of $70.79 million for fiscal year 2025.
- Nutex Health Inc. showed an increase of +35.9% in Net Income compared to the prior fiscal year.
- Nutex Health Inc. reported Diluted EPS of $10.48 per share for fiscal year 2025.
- Nutex Health Inc. showed an increase of +8.2% in Diluted EPS compared to the prior fiscal year.
- Nutex Health Inc. reported Total Assets of $918.52 million for fiscal year 2025.
- Nutex Health Inc. showed an increase of +40.2% in Total Assets compared to the prior fiscal year.
- Nutex Health Inc. reported Cash and Equivalents of $185.57 million for fiscal year 2025.
- Nutex Health Inc. showed an increase of +356.6% in Cash and Equivalents compared to the prior fiscal year.
- Nutex Health Inc. reported Long-Term Debt of $29.17 million for fiscal year 2025.
- Nutex Health Inc. showed an increase of +29.9% in Long-Term Debt compared to the prior fiscal year.
- Nutex Health Inc. reported Stockholders Equity of $329.45 million for fiscal year 2025.
- Nutex Health Inc. showed an increase of +148.8% in Stockholders Equity compared to the prior fiscal year.
- Nutex Health Inc. reported R&D Expense of $285.9 thousand for fiscal year 2021.
- Nutex Health Inc. showed a decrease of -48.7% in R&D Expense compared to the prior fiscal year.
- Nutex Health Inc. reported Operating Income of $275.62 million for fiscal year 2025.
- Nutex Health Inc. showed an increase of +110.9% in Operating Income compared to the prior fiscal year.
- Nutex Health Inc. reported Gross Profit of $444.28 million for fiscal year 2025.
- Nutex Health Inc. showed an increase of +126.4% in Gross Profit compared to the prior fiscal year.
- Nutex Health Inc. reported Shares Outstanding of 7.09 million shares for fiscal year 2025.
- Nutex Health Inc. showed an increase of +28.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: